KIND founder, Daniel Lubetzky, invests in new snack brand Quevos
Following a deal struck on ABC's Shark Tank, the founder of KIND Snacks, Daniel Lubetzky, has invested in Quevos, a brand of snacks made with egg whites.
KIND’s founder and executive chairman Daniel Lubetzky. Image courtesy of KIND.
Following a deal struck on ABC's Shark Tank, the founder of KIND Snacks (New York City, NY), Daniel Lubetzky, has invested in Quevos, a brand of snacks made with egg whites. Quevos’ founders, Nick Hamburger and Zack Schreier, and Lubetzky want to help more people discover their line of high-protein, high-fiber, low-carb snacks in five flavors: cheddar, sour cream & onion, sweet barbecue, Quevos rancheros, and dill pickle.
“I am excited to help Nick and Zack fulfill Quevos’ potential,” Lubetzky said in a press release. “They have created a very cool and differentiated product with huge mainstream appeal. And I love that they’ve been best friends and partner entrepreneurs since childhood.”
“Daniel is a partner and mentor who has been in our shoes building a health and wellness brand from the ground up through every stage of growth," said Hamburger and Schreier of Lubetzky. "We went into the Tank dreaming of making a deal with him and can’t believe we did! We’re so excited to learn from him and to collaborate on helping more people enjoy Quevos!"
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
